MAM
Foxtale unveils ‘Eternal Glow’ campaign with Sonali Bendre
Actor fronts Gluta-Vit C serum ad rejecting cosmetic extremes for science-led radiance.
MUMBAI: Sonali Bendre just proved that glow doesn’t need a needle sometimes all it takes is the right serum and a refusal to dim your own light. Foxtale has launched its latest campaign, ‘Eternal Glow’, starring actor Sonali Bendre as the face of its Gluta-Vit C Advanced Brightening Serum. The intimate, stripped-back film positions Bendre as the embodiment of radiance that endures beyond age, trends, and conventional beauty norms, celebrating resilience, self-belief, and consistency.
The narrative opens in a serene, clinical-white setting where Bendre calmly declines a series of cosmetic interventions fillers, glutathione shots, IV drips, syringes establishing her selective stance on beauty. The story then shifts to a gentler, science-backed solution: Foxtale’s serum, powered by an antioxidant complex of Glutathione and Vitamin C, designed to brighten, even skin tone, and deliver lasting glow without extremes. Clean visuals and sensorial close-ups build to a powerful finale as Bendre steps into the light, reinforcing that true radiance comes from trust in smart science, not shortcuts.
The collaboration marks a deliberate pivot for Foxtale, moving away from youth-obsessed endorsements toward authenticity and timeless beauty. By choosing Bendre, a figure long admired for her quiet strength and evolved self-assurance, the brand aligns with women who value real results over fleeting ideals.
In a beauty market flooded with quick fixes, Foxtale’s campaign quietly asks a louder question: why chase temporary shine when you can choose glow that lasts? With Bendre leading the way, the answer feels refreshingly clear and brilliantly lit.
MAM
Kate Rouch steps down as OpenAI Chief Marketing Officer
Marketing leader prioritises health after late-stage breast cancer diagnosis.
MUMBAI: When the toughest battle moves from the boardroom to the personal front, even the sharpest minds know it’s time to step back and focus on winning the most important fight of all. Kate Rouch, chief marketing officer at OpenAI, has announced she is stepping down from her role to focus on recovery following a diagnosis of late-stage breast cancer.
In a heartfelt LinkedIn post, Rouch revealed she was diagnosed around a year and a half ago, shortly after taking on the CMO position. Despite undergoing intensive treatment, she continued to lead the company’s marketing function through what she described as one of the most challenging periods of her career.
She explained that while she remained deeply committed to her role and team, she had reached a point where prioritising her health and recovery had become essential. Rouch called the decision difficult, noting it required acknowledging personal limits and shifting priorities. She reflected that the experience had reshaped her understanding of courage not always about pushing harder, but sometimes about stepping back to focus on long-term wellbeing, family and sustainability.
Rouch expressed gratitude to her team and colleagues for their support. She mentioned that Gary will step in to help lead the function and recruit a successor. She plans to support the transition and remains open to returning in a different capacity in the future, depending on her health.
Prior to joining OpenAI, Rouch served as the first chief marketing officer at Coinbase and spent over a decade at Meta, where she was vice president and global head of brand and product marketing.
She also thanked well-wishers for their messages and shared that stories from fellow survivors had a meaningful impact during her treatment journey.
In the high-stakes world of tech marketing, Kate Rouch has always been known for her strategic brilliance. Now, she is showing a different kind of strength, one that reminds us that even the most driven leaders sometimes need to pause, heal, and come back stronger when the time is right. Wishing her a full and steady recovery.
